Michael S. Lee

14.6k total citations · 1 hit paper
162 papers, 6.7k citations indexed

About

Michael S. Lee is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Michael S. Lee has authored 162 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 37 papers in Pathology and Forensic Medicine and 27 papers in Neurology. Recurrent topics in Michael S. Lee's work include Protein Structure and Dynamics (25 papers), Ophthalmology and Eye Disorders (21 papers) and Colorectal Cancer Treatments and Studies (14 papers). Michael S. Lee is often cited by papers focused on Protein Structure and Dynamics (25 papers), Ophthalmology and Eye Disorders (21 papers) and Colorectal Cancer Treatments and Studies (14 papers). Michael S. Lee collaborates with scholars based in United States, Netherlands and Italy. Michael S. Lee's co-authors include Charles L. Brooks, Freddie R. Salsbury, Wonpil Im, Mark A. Olson, Michael Feig, Martin Head‐Gordon, Richard N. Trelease, Scott Kopetz, Robert T. Mullen and David G. Menter and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael S. Lee

151 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Generalized born model with a simple smoothing function

2003 544 citations Michael S. Lee et al. profile →

Peers

Countries citing papers authored by Michael S. Lee

Since Specialization

Citations

This map shows the geographic impact of Michael S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Lee more than expected).

Fields of papers citing papers by Michael S. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Lee. The network helps show where Michael S. Lee may publish in the future.

Co-authorship network of co-authors of Michael S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Lee. A scholar is included among the top collaborators of Michael S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Lee. Michael S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS / NRAS / BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer 2025 ·Ashwin Somasundaram, Dominic T. Moore, Anita Turk, Iman Imanirad, Stacey A. Cohen, Kristen K. Ciombor, (unknown), Autumn J. McRee, Michael S. Lee, Hanna K. Sanoff	1
2	Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review 2025 ·Annals of Surgical Oncology ·(unknown), Michael S. Lee, (unknown), Samantha Kaplan, Brett T. Phillips, Akiko Chiba, Jennifer K. Plichta	0
3	Ethnic foods serving cultural bridge or barrier? A systematic literature review 2024 ·International Journal of Intercultural Relations ·Rana Muhammad Ayyub, (unknown), (unknown), (unknown), Michael S. Lee	0
4	A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer 2024 ·The Oncologist ·Hanna K. Sanoff, Allison M. Deal, Jai N. Patel, (unknown), (unknown), Bert H. O’Neil, Anita Turk, William Irvin, Jeremiah Boles, Michael S. Lee, (unknown), (unknown), Karen E. Weck, Ethan Basch, William A. Wood, (unknown)	1
5	Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination 2023 ·Cancer Research Communications ·(unknown), Jane V. Thomas, Kaysia Ludford, Jason Willis, (unknown), Kanwal Raghav, Benny Johnson, Arvind Dasari, Bryan K. Kee, Christine M. Parseghian, Michael S. Lee, (unknown), Maria Pia Morelli, John Paul Shen, (unknown), Eduardo Vilar, Robert A. Wolff, Scott Kopetz, Michael J. Overman, Van K. Morris	4
6	The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers 2023 ·Clinical Cancer Research ·Michael S. Lee, Ahmed O. Kaseb, Shubham Pant	7
7	Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6 2022 ·Cancer Research ·Alexey V. Sorokin, Preeti Kanikarla Marie, (unknown), (unknown), (unknown), Ganiraju C. Manyam, Lawrence N. Kwong, Benny Johnson, Van K. Morris, Philip Jones, David G. Menter, Michael S. Lee, Scott Kopetz	37
8	Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer 2022 ·The Oncologist ·(unknown), Dominic T. Moore, Matthew J. Reilley, Mohamed E. Salem, (unknown), Hanna K. Sanoff, Autumn J. McRee, Michael S. Lee	9
9	Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib 2020 ·Molecular Cancer Therapeutics ·Yingmiao Liu, Jing Lyu, Kirsten B. Burdett, Alexander B. Sibley, Ace J. Hatch, Mark D. Starr, John C. Brady, (unknown), Federica Marmorino, Daniele Rossini, Richard M. Goldberg, Alfredo Falcone, Chiara Cremolini, Kouros Owzar, Anastasia Ivanova, Dominic T. Moore, Michael S. Lee, Hanna K. Sanoff, Federico Innocenti, Andrew B. Nixon	15
10	Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Hanna K. Sanoff, Dominic H. Moon, Dominic T. Moore, Jeremiah Boles, (unknown), William Blackstock, Bert H. O’Neil, Somasundaram Subramaniam, Autumn J. McRee, Cheryl A. Carlson, Michael S. Lee, Joel E. Tepper, Andrew Z. Wang	53
11	Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia 2019 ·Schizophrenia Research ·(unknown), (unknown), Linda K. McLoon, Théoden I. Netoff, Michael S. Lee, Angus W. MacDonald, Robert F. Miller	16
12	Strabismus Measurements in Adults Before and After Pupil Dilation 2017 ·American Journal of Ophthalmology ·(unknown), Michael S. Lee, Scott Lunos, Jill S. Anderson, Erick D. Bothun	0
13	Progressive External Ophthalmoplegia 2016 ·Current Neurology and Neuroscience Reports ·Collin M. McClelland, Georgios Manousakis, Michael S. Lee	57
14	Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes 2016 ·Journal of Neuro-Ophthalmology ·(unknown), Peter H. Tang, (unknown), Michael S. Lee	10
15	Isolated Third, Fourth, and Sixth Cranial Nerve Palsies from Presumed Microvascular versus Other Causes 2013 ·Ophthalmology ·Madhura A. Tamhankar, Valérie Biousse, Gui‐Shuang Ying, Sashank Prasad, Prem S. Subramanian, Michael S. Lee, Eric Eggenberger, Heather E. Moss, Stacy L. Pineles, Jeffrey L. Bennett, Benjamin Osborne, Nicholas J. Volpe, Grant T. Liu, Bonnie Bruce, Nancy J. Newman, Steven Galetta, Laura J. Balcer	133
16	Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection 2012 ·PLoS ONE ·Jeffrey R. Kugelman, Michael S. Lee, Cynthia A. Rossi, Sarah McCarthy, Sheli R. Radoshitzky, John M. Dye, Lisa E. Hensley, Anna N. Honko, Jens H. Kuhn, Peter B. Jahrling, Travis K. Warren, Chris A. Whitehouse, Sina Bavari, Gustavo Palacios	34
17	Ocular treatment of thyroid eye disease 2010 ·Expert Review of Ophthalmology ·(unknown), Andrew R. Harrison, Erick D. Bothun, Linda K. McLoon, Michael S. Lee	6
18	Multiple Sclerosis on Steroids 2010 ·Survey of Ophthalmology ·Matthew Johnson, Michael S. Lee, Brian R. Younge, Valerie A. Purvin	1
19	Molecular Dynamics Simulations of Folding and Insertion of the Ebola Virus Fusion Peptide into a Membrane Bilayer 2008 ·Mark A. Olson, In‐Chul Yeh, Michael S. Lee	1
20	Extensive Antibody Cross-reactivity among Infectious Gram-negative Bacteria Revealed by Proteome Microarray Analysis 2008 ·Molecular & Cellular Proteomics ·(unknown), Kara Schmid, Michael S. Lee, James M. Meegan, (unknown), Minto Michael, Alexander P. Tikhonov, Barry Schweitzer, Robert G. Ulrich	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact